(VIANEWS) – The Market ended the session with ONWARD MEDICAL (ONWD.BR) jumping 10.68% to €4.87 on Thursday, after four consecutive sessions in a row of losses. BEL 20 slid 1.04% to €3,661.42, after two consecutive sessions in a row of gains, on what was an all-around down trend trading session today.
ONWARD MEDICAL’s last close was €4.40, 33.13% under its 52-week high of €6.58.
About ONWARD MEDICAL
Onward Medical N.V., a medical technology company, focuses on developing therapies for spinal cord injuries in the Netherlands and internationally. The company engages in developing ARC-EX, an external non-invasive platform that consists of a wearable stimulator and wireless programmer; and ARCIM, an implantable platform, which consists of an implantable pulse generator and lead that is placed near the spinal cord. It also engages in developing Up-LIFT Trial to evaluate the safety and effectiveness of non-invasive electrical spinal cord stimulation to treat upper extremity functional deficits with chronic tetraplegia. The company was founded in 2014 and is headquartered in Eindhoven, Netherlands.
Earnings Per Share
As for profitability, ONWARD MEDICAL has a trailing twelve months EPS of €-1.2.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -69.93%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 3.6%, now sitting on 2.11M for the twelve trailing months.
Volume
Today’s last reported volume for ONWARD MEDICAL is 50167 which is 32.17% below its average volume of 73967.
Moving Average
ONWARD MEDICAL’s value is way above its 50-day moving average of €3.53 and way above its 200-day moving average of €4.19.
More news about ONWARD MEDICAL (ONWD.BR).
